Bio-Rad Laboratories, Inc. (BIO)
-NYSE 116.02 May 17, 4:00PM EDT
| Prev Close: | 116.02 |
|---|
| Open: | N/A |
|---|
| Bid: | N/A |
|---|
| Ask: | N/A |
|---|
| 1y Target Est: | 132.75 |
|---|
| Beta: | 1.23 |
|---|
| Next Earnings Date: | 5-Aug-13 |
|---|
| Day's Range: | N/A - N/A |
|---|
| 52wk Range: | 91.52 - 127.17 |
|---|
| Volume: | 0 |
|---|
| Avg Vol (3m): | 85,848 |
|---|
| Market Cap: | 3.31B |
|---|
| P/E (ttm): | 21.87 |
|---|
| EPS (ttm): | 5.31 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- BIO RAD LABORATORIES INC FinancialsEDGAR Online Financials(Fri, May 17)
- Danaher Proves Even The Nimble Can Stumbleat Investopedia(Tue, May 14)
- Bio-Rad Named One of the 'Best Places to Work 2013' in the San Francisco Bay AreaMarketwired(Mon, May 13)
- 5 Healthcare Stock Earnings Snapshotsat Wall St. Cheat Sheet(Sun, May 12)
- BIO RAD LABORATORIES INC Files SEC form 10-Q, Quarterly ReportEDGAR Online(Fri, May 10)
- Earnings Miss at SurModicsZacks(Wed, May 8)
- Bio-Rad Laboratories Whiffs on Earningsat Motley Fool(Wed, May 8)
- Bio-Rad Laboratories Management Discusses Q1 2013 Results - Earnings Call Transcriptat Seeking Alpha(Tue, May 7)
- Bio-Rad Labs Earnings: Here’s Why Investors Like These Resultsat Wall St. Cheat Sheet(Tue, May 7)
- Bio-Rad Reports First-Quarter 2013 Financial ResultsMarketwired(Tue, May 7)
- BIO RAD LABORATORIES INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements andEDGAR Online(Tue, May 7)
- Bio-Rad Laboratories Earnings: Your Sneak Peek to the Big Announcementat Wall St. Cheat Sheet(Tue, May 7)
- Q1 2013 Bio-Rad Laboratories, Inc. Earnings Release - After Market CloseCCBN(Tue, May 7)
- Bio-Rad coverage assumed with a Buy at Jefferiestheflyonthewall.com(Tue, May 7)
- The Daily Startup: Gene-Research Tools Co. RainDance to Grow Salesat The Wall Street Journal(Mon, Apr 29)
Key Statistics
| Forward P/E (1 yr): | 18.42 |
|---|
| P/S (ttm): | 1.59 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | 5.12 |
|---|
| Quarterly EPS Est
(Jun-13)
: | 1.24 |
|---|
| Mean Recommendation*: | 1.8 |
|---|
| PEG Ratio (5 yr expected): | 2.29 |
|---|
Business Summary
Bio-Rad Laboratories, Inc. manufactures and supplies products and systems used to separate complex chemical and biological materials, and to identify, analyze, and purify their components for life science research, healthcare, analytical chemistry...
View More